129 related articles for article (PubMed ID: 2120741)
1. Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up.
Amdur RJ; Parsons JT; Fitzgerald LT; Million RR
Radiother Oncol; 1990 Jul; 18(3):235-46. PubMed ID: 2120741
[TBL] [Abstract][Full Text] [Related]
2. Results of external beam radiotherapy in 448 patients with clinically localized adenocarcinoma of the prostate.
Mameghan H; Fisher R; Mameghan J; Brook S
Aust N Z J Surg; 1994 Jun; 64(6):389-94. PubMed ID: 8010899
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and mortality of local failure after definitive therapy for prostate cancer.
Schellhammer PF; Whitmore RB; Kuban DA; el-Mahdi AM; Ladaga LA
J Urol; 1989 Mar; 141(3):567-71. PubMed ID: 2918594
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the prostate: local control with external beam radiation therapy.
Gibbons RP; Mason JT; Correa RJ; Cummings KB; Taylor WJ; Hafermann MD; Richardson RG
J Urol; 1979 Mar; 121(3):310-2. PubMed ID: 107328
[TBL] [Abstract][Full Text] [Related]
5. External beam radiotherapy for carcinoma of the prostate.
Sagerman RH; Chun HC; King GA; Chung CT; Dalal PS
Cancer; 1989 Jun; 63(12):2468-74. PubMed ID: 2720597
[TBL] [Abstract][Full Text] [Related]
6. The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy.
Amdur RJ; Parsons JT; Fitzgerald LT; Million RR
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1377-82. PubMed ID: 2262361
[TBL] [Abstract][Full Text] [Related]
7. The influence of transurethral resection of prostate on prognosis of patients with adenocarcinoma of the prostate treated by radical radiotherapy.
Duncan W; Catton CN; Warde P; Gospodarowicz MK; Munro AJ; Lakier R; Simm J; Panzarella T
Radiother Oncol; 1994 Apr; 31(1):41-50. PubMed ID: 8041897
[TBL] [Abstract][Full Text] [Related]
8. [Treatment results with external radiotherapy in prostate cancer].
Prada Gómez PJ; Alonso García A; Canteli Castañón M; Olay Gayoso L; Alonso Pantiga R; Rijo GJ; Rodríguez Fernández R; Querejeta Recalde A; Castillo AF; Matallanas Bermejo M; Fernández García J; Vivanco Parellada J
Arch Esp Urol; 1998 Nov; 51(9):890-6. PubMed ID: 9887562
[TBL] [Abstract][Full Text] [Related]
9. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
Stromberg J; Martinez A; Benson R; Garton G; Diokno A; Gonzalez J; Zincke H; Schray M; Edmundson G; Brabbins D
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):67-75. PubMed ID: 8270460
[TBL] [Abstract][Full Text] [Related]
10. Teletherapy for stage C adenocarcinoma of the prostate.
Lupu AN; Petrovich Z; Corvalan J; Katske FA; Kaufman JJ
J Urol; 1982 Jul; 128(1):75-8. PubMed ID: 7109076
[TBL] [Abstract][Full Text] [Related]
11. Interstitial gold and external beam irradiation for prostate cancer.
Boileau MA; Dowling RA; Gonzales M; Handel PH; Benson GS; Corriere JN
J Urol; 1988 May; 139(5):985-8. PubMed ID: 3129584
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate.
Perez CA; Garcia D; Simpson JR; Zivnuska F; Lockett MA
Radiother Oncol; 1989 Sep; 16(1):1-21. PubMed ID: 2554371
[TBL] [Abstract][Full Text] [Related]
13. Definitive external irradiation in stages A (T1) and B (T2) carcinoma of the prostate.
Perez CA; Kirchmann E; Lockett MA
Am J Clin Oncol; 1993 Oct; 16(5):377-88. PubMed ID: 8213619
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for adenocarcinoma of the prostate.
Bruce AW; Mahan DE; Lott S
Can J Surg; 1979 Sep; 22(5):424-7. PubMed ID: 497909
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer.
Galalae RM; Kovács G; Schultze J; Loch T; Rzehak P; Wilhelm R; Bertermann H; Buschbeck B; Kohr P; Kimmig B
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):81-90. PubMed ID: 11777625
[TBL] [Abstract][Full Text] [Related]
16. Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels.
Dugan TC; Shipley WU; Young RH; Verhey LJ; Althausen AF; Heney NM; McManus PL; Abraham EH
J Urol; 1991 Nov; 146(5):1313-6. PubMed ID: 1719244
[TBL] [Abstract][Full Text] [Related]
17. Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis.
Spratt DE; Zumsteg Z; Ghadjar P; Pangasa M; Pei X; Fine SW; Yamada Y; Kollmeier M; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1254-61. PubMed ID: 23182392
[TBL] [Abstract][Full Text] [Related]
18. Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome.
Kupelian PA; Buchsbaum JC; Elshaikh MA; Reddy CA; Klein EA
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):629-34. PubMed ID: 14529766
[TBL] [Abstract][Full Text] [Related]
19. Prostatic carcinoma: limited field irradiation.
Rounsaville MC; Green JP; Vaeth JM; Purdon RP; Heltzel MM
Int J Radiat Oncol Biol Phys; 1987 Jul; 13(7):1013-20. PubMed ID: 3597143
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy following radical prostatectomy in patients with adenocarcinoma of the prostate.
Petrovich Z; Lieskovsky G; Langholz B; Luxton G; Jozsef G; Skinner DG
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):949-54. PubMed ID: 1917624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]